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Abstract
Background: The rising prevalence of chronic diseases is pressing health systems to introduce reforms. Primary
healthcare and multidisciplinary models have been suggested as approaches to deal with this challenge, with new roles
for nurses and pharmacists being advocated. More recently, implementing healthcare based on information systems and
technologies (e.g. eHealth) has been proposed as a way to improve health services. However, implementing online
pharmaceutical services, including their adoption by pharmacists and patients, is still an open research question. In this
paper we present ePharmacare, a new online pharmaceutical service implemented using Design Science Research.
Methods: The Design Science Research Methodology (DSRM) was chosen to implement this online service for chronic
diseases management. In the paper, DSRM’s different activities are explained, from the definition of the problem to the
evaluation of the artifact. During the design and development activities, surveys, observations, focus groups, and eye-
tracking glasses were used to validate pharmacists’ and patients’ requirements. During the demonstration and evaluation
activities the new service was used with real-world pharmacists and patients.
Results: The results show the contribution of DSRM in the implementation of online services for pharmacies. We found
that pharmacists spend only 50% of their time interacting with patients, uncovering a clear opportunity to implement
online pharmaceutical care services. On the other hand, patients that regularly visit the same pharmacy recognize the
value in patient follow-up demanding to use channels such as the Internet for their pharmacy interactions. Limitations
were identified regarding the high workload of pharmacists, but particularly their lack of know-how and experience in
dealing with information systems (IST) for the provision of pharmaceutical services.
Conclusions: This paper summarizes a research project in which an online pharmaceutical service was proposed,
designed, developed, demonstrated and evaluated using DSRM. The main barriers for pharmacists’ adoption of online
pharmaceutical services provision were the lack of time, time management and information systems usage skills, as well
as a precise role definition within pharmacies. These problems can be addressed with proper training and services
reorganization, two proposals to be investigated in future works.
Keywords: Pharmaceutical services, Services implementation, Online services, Patient experience, Design science
research
Background
Chronic diseases are already the main cause of mortality
in Europe, and are becoming a challenge for middle and
low income economies due to the demographic and epi-
demiological transitions taking place [1]. The increasing
prevalence of chronic diseases is inducing health system
reforms with interprofessional collaboration in primary
care emerging as a model of integrated healthcare ser-
vice provision [2, 3]. The goal of these multidisciplinary
models is to transform the daily care of chronic patients,
assigning major roles for non-physicians, such as com-
munity pharmacists (CP) and nurses [4–6].
The focus on multidisciplinary models of care and the
consequent primary healthcare reforms are encouraging
the rethinking of community pharmacists’ role [7]. Com-
munity Pharmacy orientation towards a patient-centered
practice has become the new paradigm of pharmacy
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practice, supported by the development of a clinical role
for community pharmacists and a more active role for
patients in their own disease management [8, 9]. This
new paradigm has led to the development of new
“pharmaceutical services” concepts [10].
There are a number of different services performed by
pharmacists in different countries that match CP’s role
in primary healthcare. These services range from the
traditional distribution services to more advanced dis-
ease management services [11, 12]. Moreover, pharma-
ceutical services have been considered extremely
valuable for professionals, patients and healthcare systems,
mainly due to a greater efficiency and improvement in in-
dividual patient’s health related outcomes [4, 9, 13].
Costa and colleagues [14] have described the status
and outlined the trends of community pharmacy services
in Portugal. CP in Portugal work exclusively in inde-
pendent pharmacies, since large chains are not allowed.
The opening of community pharmacies is regulated by
the national medicines regulatory agency (INFARMED).
Pharmacies have a National Health Service (NHS) con-
tract for dispensing prescription medicines, with legisla-
tion establishing medicines’ profit margins and patients’
co-payments [15] Over the last twenty years Portuguese
community pharmacies have developed consultation ser-
vices to manage chronic patients and their therapies, in
line with international developments on “pharmaceutical
services” [14, 16].
Good communication between professionals is essen-
tial in multidisciplinary practice, making Information
Systems and Technologies (IST) a prerequisite under-
pinning healthcare services in future health systems [17].
The continuous development of IST led to the onset
of eHealth, that can be defined as “the utilization of
IST to support health service provision, complying
with the needs of citizens, patients, health profes-
sionals and other providers” [18]. IST in healthcare
have been used primarily to improve administrative
management. However, implementation of eHealth
services has the potential to promote a better access
to information by patients and providers, improve the
quality, efficacy and safety of healthcare services, and
encourage healthier lifestyles [19–21].
Investing in IST and modernizing the architecture of
pharmacies is considered as a necessary and critical step
towards the diffusion of new forms of practice [22, 23].
eHealth services may develop in the next few years to
harvest the full potential of CP, enhancing their role in
the primary care network and supporting their activities
in chronic disease management [24].
However, difficulties in eHealth implementation are
frequently reported [25, 26]. Most of these difficulties
are frequently attributed to managerial and behavioral
factors [27]. To resolve these difficulties, some authors
propose that a user centered approach should be pro-
moted to be certain that eHealth services will satisfy
user’s needs [28]. The user centered approach also
reinforce users’ ownership of the system leading to
higher compliance and ongoing use of the system [29].
The complex characteristics of the problems affecting
health systems worldwide demand new ideas and inno-
vations, aiming at more responsive healthcare services
[30]. The implementation of multidisciplinary services
models requires proper planning and management, espe-
cially when innovation experience and patient know-
ledge is lacking. The ePharmacare project was designed
considering all these challenges. The main goal of this
project was to explore the development of eHealth used
to address the challenges of community pharmacists’ in-
tegration with primary healthcare services. Additionally,
the project would also assess the potential of eHealth in
the provision of pharmaceutical services by actively en-
abling the interaction with patients and promoting their
education. Furthermore, the project is expected to ad-
dress the use of eHealth supporting health services, es-
tablishing its acceptability, feasibility, sustainability, and
adaptability to future changes.
In order to achieve these objectives, an online pharma-
ceutical service was conceived, designed, developed,
demonstrated and evaluated using the Design Science
Research Methodology (DSRM) [31, 32]. This service
(e.g. an artifact for DSRM) would support patients’ dis-
ease and therapeutic monitoring by a CP. Patients were
enrolled in an active way, advising them to use the ser-
vice to interact with pharmacists. Information about pa-
tients can be used to understand patients’ treatment
effects and success rate, but that information is also
valuable for assessing the service acceptability and
usability.
After this introduction, the paper is divided in three
sections. In the next section, we highlight the research
method used for designing, demonstrating and evaluat-
ing the service. Results section presents the results ac-
cording to the activities that support DSRM [31].
Discussion section analyzes and discusses the results in
more detail. The paper then closes with a conclusion
that includes the main lessons learned plus future work.
Methods
The implementation of online services in a healthcare
practice presents several challenges [25]. The design of
the service must be adequate to both practitioners and
users, as well as cost-effective. On the other hand, the
utilization of an online health service has the potential
to impact user behavior and perceived usefulness [20].
Therefore, there is a need to use a research method that
takes into account the interaction between health profes-
sionals and the end user.
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The Design Science Research Methodology (DSRM)
[31, 32] was chosen since DSRM has demonstrated its
ability to study the connection between research and
professional practices by designing, implementing and
evaluating artifacts that address a specific need. In fact,
DSRM studies the artificial - any phenomena created by
humans - in a rigorous process of proposing artifacts to
solve problems, evaluating what has been projected or
what is functioning, and communicating the obtained
results [33].
The main output of a DSRM project must be an
artifact. In this case, the artifact will be an eHealth
pharmaceutical service. Hevner and colleagues [32] have
established guidelines for a consequent DSRM study.
Later, Peffers and colleagues [31] proposed converting
those guidelines into six activities. For the research pre-
sented in this paper, these six activities had a specific set
of tasks (Table 1).
In the remaining of this section, an explanation of the
tasks performed in each activity is provided in more
detail.
Activity 1 - Identify problem & motivate
In order to setup the context for this research, a scenario
planning exercise was performed to design future sce-
narios for Portuguese community pharmacists. The exer-
cise recognized the changing environment as a huge
challenge but also an opportunity to develop the role
that community pharmacists may play in the Portuguese
health system. For this exercise two objectives were con-
sidered: (i) to analyze the possible evolution of commu-
nity pharmacists’ role in the Portuguese healthcare
system by building and studying three different scenar-
ios, and (ii) to identify the main driving forces and re-
lated uncertainties that may impact on the definition of
the future community pharmacists’ role [23].
Furthermore, an online survey was launched to obtain
a general overview of the current state of pharmaceutical
services provision and the IST usage in community
pharmacies, based on a previously developed survey per-
formed in Switzerland [34]. The survey was translated
and validated with two academic researchers specialized
on Portuguese community pharmacies. The survey was
implemented using Google® Forms, and then sent via
email to 323 pharmacies members of the Association of
Portuguese Pharmacies (AFP).
Following this online survey, an observational time-
and-motion study was performed to study pharmacists’
work patterns and pharmaceutical care services’ poten-
tial demand [35, 36]. The observational study was per-
formed in four pharmacies of the metropolitan Lisbon
area, during an eight hours full shift. The objective was
to understand the potential value of an online pharma-
ceutical service, and how that service might fit in a phar-
macist’s workday [37]. The study characterized the
activities performed by CP, including the entire array of
provided services, time spent with patients, and an esti-
mation of chronic patients’ yearly visits to a pharmacy.
Using the main outputs of the observational study, such
as the time spent performing a service and the activities
required to carry out each service, it was possible to de-
termine the costs of current pharmaceutical services be-
ing provided, through a Time-driven Activity Based Cost
analysis [38]. After finding all the activity cost-rates, it is
possible to determine the cost of a specific service, using
the following time equation (where tn is the average time
spent in each activity necessary to a certain service):
Service cost ¼ t1  cost rate1ð Þ þ t2  cost rate2ð Þ
þ t3  cost rate3ð Þ þ tn  cost ratenð Þ
Activity 2 - Defining objectives of a solution
The aim of this activity was to identify the services re-
quired by patients when they interact with pharmacies.
The identification of those services, helped to define fea-
tures of the online service. The final objective of this ac-
tivity was to inform the design of an online service with
functionalities that potential customers felt lacking in
their community pharmacy experience, added to func-
tionalities that could mimic the work processes of the
Dáder methodology for pharmaceutical care provision
[39]. A set of 50 semi-structured interviews focusing on
customer service were performed, with patients at health
centers and hospitals in Lisbon and Oporto [40]. The
interview guide was developed with the aim of gathering
Table 1 DSRM activities and respective tasks
DSRM activity Tasks
1. Identify problem &
motivate
Setup the context using a scenario design
for Portuguese pharmacists in 2020.
Online survey of IST utilization in Portuguese
pharmacies.
Observational time-and-motion study to
assess pharmacists’ current work patterns
and potential demand for pharmaceutical
care services
Cost of current pharmaceutical services
2. Define objectives of a
solution
Set of qualitative interviews performed
within primary health centers and hospitals
3. Design & development Design of artifact (online service based on a
software platform) for pharmaceutical care
provision
4. Demonstration Field study to test the platform in two
settings with a selected group of patients
5. Evaluation The usability of the platform was assessed
through the use of “task scenarios” with
eye-tracking glasses and semi-structured
interviews of the participants
6. Communication Practitioners, conference communications,
journal papers, and theses.
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opinions regarding the current service concept offered
by community pharmacies, as well as what customers
would like to have within existing or new services [41].
These interviews also identified the most critical service
failures that customers experienced, and collected feed-
back about potential solutions. The interviewees were
selected among patients of different age groups in the
waiting rooms of these health services, after their con-
sent to participate was obtained verbally by the inde-
pendent researcher following a brief explanation of the
interview’s objective. The interviews were performed in
person and audio-recorded, following an interview guide
previously developed.
Activity 3 - Design & development
The design and development of the online pharmaceut-
ical service was based on the Dáder methodology for
pharmaceutical care and Service Experiment Blueprint
concepts, enabling the design of service characteristics
and functionalities required by chronic patients [39, 42].
Service Experience Blueprint (SEB) ensures a customer
driven design able to co-create value with end customers
[42, 43]. The SEB method enhances the design of cus-
tomer experiences, especially for technology-enabled
services and contributes for a stronger focus on
customer-firm relationship. Modelling methodologies
can also provide an additional understanding of the dy-
namics of an organization to better align pharmacy ser-
vices’ design with operations [44].
The design and development of the software platform
(that supports the online service) was based on the Agile
methodology, [45, 46] using “sprints” of seven days man-
aged on Trello® online service. After the end of each
sprint, a new version of the software platform was pub-
lished in order to be immediately used by pharmacists
and patients. This methodology permits the collection of
feedback from end users almost continuously, so that
new features are prioritized in order to extract max-
imum value from the service.
Activity 4 - Demonstration
In this activity, the utility (for patients and pharmacists)
of the proposed online service was demonstrated. The
online service was tested in two different settings
during nine months: (i) three CP working within
three of the observational study’s community pharma-
cies using the service and face-to-face consultations
to interact with patients (Pharmacists “P”); (ii) a CP
using the service and scheduled meetings interacted
with patients without the possibility of dispensing
medicines (Pharmacist “C”). The main criteria to se-
lect pharmacists among the pharmacy’s staff was their
ability and certification to provide pharmaceutical care
services. Pharmacist “C” used the platform outside the
community pharmacy to recruit patients among people
of a Senior Citizens University in a Lisbon municipal-
ity and was also a certified pharmacist. A Senior
Citizen University is a service provided by some muni-
cipalities, sometimes supported by official schools,
where seniors (people with more than 65 years of age)
go to pass their time and have learning activities. Among
those activities, there usually are some Information tech-
nology classes.
The target users were purposively selected among pa-
tients that presented at least one prescription for chronic
medicines and were active users of the internet. Patients
were recruited during the first two months of the study
according to the following criteria: to have a prescription
of a hypertensive, antidiabetic or anti-cholesterol medi-
cine; to have more than 65 years of age; to be an active
Internet user. A survey was applied to determine pa-
tient’s internet utilization patterns. Pharmacist’s inter-
vention included: patient education about medicines,
completion of a drug therapy profile and drug history,
assessment of initial drug compliance and patient coun-
seling about lifestyle modifications. Initial training was
given both to pharmacists and patients, and follow-up
training was provided when needed.
Activity 5 - Evaluation
The evaluation took place eight months after the start of
the demonstration activity, and included tests with four
pharmacists and three patients. The tests were based on
a set of tasks executed by pharmacists and patients
(Table 2). Eye-tracking glasses were used to determine
which platform features were looked upon when per-
forming each set of tasks and how long it took, in order
to identify major bottlenecks in users’ experience of the
platform. All testers were interviewed to provide more
information about the utility of the online service and to
identify missing features.
Activity 6 – Communication
The Communication activity aim at disseminating the
project’s results. This activity was performed throughout
the duration of the research project and consisted in oral
communications, papers published in conference pro-
ceedings within the fields of study and three papers
already published in peer reviewed journals [23, 37, 38].
Data analysis
Statistical and other data analyses were performed with
MS Excel® and SPSS® (Software Package for Social
Sciences; Version 20, IBM, Chicago, IL). The content
analysis of the qualitative interviews was performed with
Computer Assisted Qualitative Data Analysis Software
(CAQDAS) – QSR NVIVO® 10. All data were kept an-
onymous and confidential.
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Results
The utilization of DSRM’s six activities produced results
which are presented in the following sub-sections. After
these sections, a discussion section ensues with an over-
all discussion about the results, the consequences for
community pharmacists and a critical appraisal of the
DSRM.
Activity 1: Identify problem and motivate
The problem identification activity is crucial to help
focus the DSRM and to guarantee user involvement.
Three complementary approaches were used to define
the problem: a scenario exercise, an online survey, and
an observational study.
a) Scenario exercise
The scenario analysis highlighted that the development
of a new role for community pharmacists is dependent
on the economic and legislative environment in which
these professionals operate and also of their inner ability
to innovate and develop new services. In a scenario
where online pharmaceutical services would be a reality
across the country, new health regulations have to be in
place alongside a more competitive pharmacy market.
Besides that, an innovative approach by pharmacy man-
agers and practicing CP will be needed.
b) Online survey
The online survey had a low response rate (n = 16/323;
4.95%). In the respondent pharmacies, the average num-
ber of computers was 5 (min: 2; max: 10), with a ratio of
2.5 computer per pharmacy. All respondent pharmacies
use IST for medicine dispensing and administrative tasks
(stock management, reimbursement activities) (Fig. 1).
Approximately a quarter of respondent pharmacies
have an Internet site and 38% have a social network
presence. All respondent pharmacies claimed to check
their email daily, although only 15% claim to have used
the email to answer patients’ queries, and do so less than
5 times a month. To the question “what is the most
important barrier to eHealth service provision in
Pharmacy” all (100%) the respondents were unanimous
in two options: the lack of financial incentives for online
pharmaceutical services implementation and lack of sup-
port and guidance from professional organizations.
c) Observational study
The observational study took place during a week-
day’s full 8 hours shift. In total, 16 pharmacists were ob-
served. Eighty-five percent of the observed tasks were
performed by pharmacists, equivalent to 65% of the total
recorded time. Among the recorded tasks, between 77
and 85% had some sort of medicine dispensed. During
the observation, professionals interacted on average with
40 customers, with 54% of the interactions occurring in
the afternoon period (3 p.m. – 7 p.m.). About 54 minutes
of free or idle time per pharmacist were found. However,
the majority of the free time is spent in micro pauses,
with 50% of the recorded breaks having less than 50 sec-
onds while 11% were between 5 and 30 minutes in
duration. Regarding the provision of pharmaceutical ser-
vices, 29.9% of pharmacist time was spent dispensing
prescriptions and 13.2% dispensing Over-the-counter
(OTC) medicines. Also of relevance is the 4.3% of
pharmacist time that was spent counselling patients
without dispensing any medicine (Fig. 2).
Concerning other activities performed by pharmacists,
32.7% of pharmacists’ time was spent in administrative
tasks, including ordering and storage of medicines, pre-
paring prescriptions for reimbursement issues, and
meetings with vendors and salespersons. In the recorded
observations, the only service provided using an IST was
the dispensing service. The IST was used to support
sales, detecting possible interactions and identifying ad-
verse effects of the dispensed medicines.
Table 2 Tasks developed for testing the online service
Pharmacist tasks Patient tasks
Scenario I -. Enter the ePharmacare platform with your username and
password. Look for the date of the next visit to your user XXX.
Scenario II - Add a new medicine for the user XXX: Ben-u-ron 500 mg,
20 tablets; take one tablet after breakfast and one after dinner. Set the
end date of package.
Scenario III - Send a message to the user XXX: TEST.
Scenario IV - Add the value of postprandial glucose of 182 mg/dL for
the user XXX.
Scenario V - Find the last blood pressure to the user XXX.
Scenario VI - Arrange a visit for the user YYY for the day 07/20/2014,
10:00 am.
Scenario VII - Verify the value of total cholesterol to user XXX.
Scenario VIII - Verify that the user forum has calculated BMI.
Scenario I -. Enter the ePharmacare platform with your username and
password. Seek new messages.
Scenario II - Add the value of fasting glucose of 182 mg/dL.
Scenario III – Add the blood pressure value 135/85 mm/Hg.
Scenario IV – Add the height and weight values.
Scenario V - Find the last blood pressure value.
Scenario VI – Add a new medicine to the user profile: Ben-u-ron
1000 mg, 18 tablets'; take one tablet after breakfast and one after
dinner.
Scenario VII – Verify your next appointment with the Pharmacist.
Scenario VIII – Send a message “TEST” to the CP.
Scenario IX – Find the end date for the package of Ben-u-ron.
Scenario X – You have been taking two cups of green tea daily,
add this information to your profile.
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d) Costing study
In general, pharmaceutical services costs in the partici-
pant pharmacies were similar. The average cost for the
dispensing service was €3.66; OTC dispensing average
cost was €2.16; for the counselling service, the average
cost was €1.34; Health screening services’ average costs
were €3.59. The costing study also identified the most
costly activities in pharmaceutical service provision. In
these pharmacies, validation and dispensing of the pre-
scription and the managing of inventory and other re-
cords, were found to be the highest-cost activities.
Activity 2: Define objectives of a solution
After the problem identification activity, DSRM pro-
poses the definition of objectives for a solution. To
identify service requirements, a set of 50 qualitative in-
terviews were performed. The qualitative research was
undertaken in the hospitals of S. João (Porto) and Egas
Moniz (Lisbon), and in the healthcare centers of
Campanhã (Porto) and Ajuda (Lisbon). The interviewees
were 24 males and 26 females (mean age of 44.4 years)
that answered questions about community pharmacy
services. 62% of the interviewees reported visiting a
pharmacy at least once a month. 46% of the interviewees
admitted that they sought healthcare provision with CP
for minor issues before going to a general practitioner
(GP). When asked about new pharmacy services, the
home delivery and internet ordering of medicines were
the most referred services, followed by integrating phar-
macy services with primary care (e.g. gatekeeping, sched-
uling of GP consultations, patient follow-up).
Fig. 1 Characterization of Information Systems and Technologies use in a convenience sample ofPortuguese Community Pharmacies
Fig. 2 Average Percentage of daily time usage by pharmacists, based on a time-motion study in 4 pharmacies
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Supported by the results from the first two activities,
the main targets for the new service were now defined.
The online pharmaceutical service should allow the
pharmaceutical care of chronic patients without over-
loading community pharmacists’ workload, at a cost
comparable to a screening service. This service should
address the monitoring of patients’ therapy (covering
medication reviews, medicine interactions, adherence
and medication management), alongside features that
aimed to test service integration with the primary
healthcare (e.g. emission of reports to the GP).
Activity 3: Design and development
From the insights obtained in the previous activities, the
design of a disease management platform to support on-
line pharmaceutical care services for chronic patients
was proposed. The platform was called ePharmacare.
The core of the platform is the storage of patient’s treat-
ment information and the possibility to improve that in-
formation by allowing both pharmacists and patients to
enter valuable information on the platform. Once phar-
macists have their patients registered in the platform, it
is possible to provide disease management on several
levels: estimation of “re-fill dates”, providing the
pharmacist with a prevision of when a re-stock and refill
of medicines is needed for a specific patient; monitoring
of therapeutic results; early detection of adverse reac-
tions, addressing minor ailments or other queries re-
ported by patients.
The built platform is able to calculate treatment end
dates and warn the pharmacist when that date is ap-
proaching, while the patient will receive a notification
email. The platform also offers patients the option to re-
quest their medicines online. This functionality supports
pharmacists and patients on the control of patient’s
therapeutic compliance and allows the streamlined
just-in-time provision of medicines, either in-pharmacy or
home delivered.
Allowing real-time monitoring of patient’s parameters
such as blood pressure or glycaemia levels is another im-
portant aspect of the platform (Fig. 3). Currently, phar-
macists monitor and register their patient’s therapeutic
progress on paper (or not at all). ePharmacare allows pa-
tients and pharmacists to enter and store these data in a
database. Pharmacists can then see, edit, organize, and
interpret the data in a more convenient way. For pa-
tients, the potential of this feature lies in the possibility
of accessing their own therapeutic and disease manage-
ment data outside of the pharmacy, thus greatly improv-
ing their own decision making.
Activity 4: Demonstration
A total of 28 patients showed interest in participating,
answering the initial recruitment survey. Eighty-eight
percent of these patients used the Internet for more than
2 years, mostly using the Internet to search for informa-
tion regarding trips and holidays (73.1%). Only 57.7% of
these patients claimed using the Internet to search for
health related information.
Two Pharmacists “P” recruited three chronic patients
each while another Pharmacist P recruited six patients.
However, none of these patients used the platform more
than once, being removed from the final analysis. Asked
about the main reasons related with recruitment’s diffi-
culty, Pharmacists “P” argued that they were too busy at-
tending patients in the pharmacy. In their opinion, the
process of recruiting patients was too long, taking about
30 minutes, including: brief explanation of the project
(~10 minutes); patient answering the survey (~15 mi-
nutes); account creation (~5 minutes); and account
verification and validation (~5 minutes). Also, they an-
ticipated non-compliance with this type of intervention
Fig. 3 Screenshot of the blood pressure monitor (pharmacist view)
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by their usual chronic patients, leading them to under-
recruit.
Pharmacist “C” recruited 16 patients, but only 10 partic-
ipated in the study during the full length of the demon-
stration. Pharmacist “C” patients held monthly meetings,
observing, discussing and registering clinical data. These
meetings finished with an information session about dif-
ferent health themes, but usually in the context of chronic
diseases, such as the proper use of medications, interac-
tions of medicines and herbal products, etc. The online in-
formation exchange between patients and Pharmacist “C”
was related to questions of therapy modifications, self-
administration of medicines or self-medication with OTC
medicines and herbal products.
Among the collected parameters, the blood pressure
and post-prandial glycaemia showed significant improve-
ments (see Table 3). However, due to the low number of
participants and the exploratory nature of the demon-
stration study, such improvements must be interpreted
with caution.
Activity 5: Evaluation
The objectives of this activity were to assess the usability
of the platform and to identify missing features in the
service, aiming to inform the next cycle of DSRM. To
help in assessing the usability of the web platform, eye-
tracking glasses were used. The tasks were performed
while the glasses recorded a video which was analyzed
afterwards.
It was found that a CP took an average of 7:38 minutes
to perform the tasks. This is an important finding since
it fits within the free time found in activity one.
Nevertheless, it is more important to highlight that to
really use this free time in an efficient way, some
reorganization of pharmacies’ internal working processes
and role-definition among professionals must be done.
For patients, the time to perform a set of tasks was con-
sidered less relevant since patients can use the platform
whenever is most convenient. The difficulties in using
IST are common among this age group and are usually
addressed in usability field studies [47]. Furthermore, the
tasks were performed under the assistance of one re-
searcher that offered help by pointing at the right tabs
and menus when necessary. Given that this help should
not be needed, the necessity to improve the design of
the platform and the training given to patients were the
first major outcomes of this evaluation.
After the eye-tracking evaluation, a semi-structured
interview followed. In this interviews, we found that to
maintain patient’s motivation to use the platform, peri-
odic meetings or consultations have to be performed.
Only when these meetings were regularly scheduled, pa-
tients used the platform to register their parameters or
communicate with the pharmacist. Patients also found
that one of the most valuable assets is the platform’s
capability to assemble patient’s therapeutic profile and to
calculate when each medicine will be finished or refilled,
based on the dose, package size and treatment duration.
The main evaluation conclusions were the following:
 Pharmacists used the ePharmacare platform without
difficulty during the usability test; Patients, however,
needed some guidance, hinting at some design flaws
and insufficient training.
 The addition of a dashboard is needed on the front
page to simplify the access to information. This was
felt by both pharmacists and patients. The font size
was found to be too small for most patients, and not
suitable for the standard screen resolution of
pharmacies’ current information system;
 Patient’s main request was to have a “text box” to add
information about non-conventional therapy, and the
possibility to edit information. Also mentioned was
the need to have a message system that allowed file
attachment (e.g. clinical analysis results)
 Patients also asked for “messages” to alert them for
therapy ending as well as to screening values out of
the ordinary or above the established objectives;
 Some pharmacists found the “send a message” and
“schedule a visit” features (which also allows sending
a message) confusing;
 In pharmacist’s opinion, the main barriers to patient
recruitment were: advanced age of patients (65-80
years); lack of time; lack of an adequate space to
practice pharmaceutical care supported by the
platform; populations’ lack of awareness; and
patients refusal to share their data with a pharmacy;
 Patient’s demonstrated satisfaction with the platform
and would like to continue to use it in their daily
routine. They found the platform comfortable and
simple to use, despite the design issues
 The lack of communication with a GP was felt by
most of the patients and by all of the pharmacists.
The communication with a GP feature was not
implemented in this study since the goal was to
address patients’ usability issues first. However,
these suggestions will be implemented in the next
research cycle.







Systolic BP (mmHg) 167 [151 – 172] 157 [137 – 164] 0.008
Diastolic BP (mmHg) 74 [71 – 80] 70 [60 – 80] 0.028
Postprandial glycaemia
(mg/dl)
257 [200 – 296] 199 [176 – 220] 0.028
*Wilcoxon signed-rank test; p-value < 0.05
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Discussion
The development of a new online pharmaceutical service
could be an important contribution to efficient chronic
diseases’ management. In this paper, a method to de-
velop and implement a platform for online pharmaceut-
ical services provision was proposed. Although the
research work reported in this paper is exploratory in
nature, the results presented provide a snapshot of
Portuguese community pharmacy and pharmacists. The
different activities of DSRM yielded important results
that may have implications for community pharmacy
and pharmacists’ future that will be discussed in this
section.
Research findings
Regarding the results of each activity, some comments
can be made. Firstly, the scenario exercise allowed to
identify the main drivers to the diffusion of new services:
community pharmacists’ ability to innovate and develop
new services is dependent not only on the “inner will” of
individual pharmacy owners toward innovation, but also
on the leadership of professional organizations such as
the Pharmaceutical Society (OF) and the National
Association of Pharmacies (ANF). Also, the economic
context and pharmacy setting has to become more com-
petitive, possibly through a liberalization of the phar-
macy market or other legislative changes that would
encourage innovators. More details on the methodology
and comprehensive discussion of this scenario exercise
can be found elsewhere [23].
The survey’s low response rate hinders our ability to
make inferences for all Portuguese pharmacies. This low
rate may also confirm the low interest in participating in
pharmacy practices studies found in other recent studies
[48, 49]. However, the results from the survey suggest
that the potential to develop online services exists. All
pharmacies are equipped with an information system
and other technological infrastructures that can be fur-
ther explored. However, pharmacy staff must be profi-
cient in the use IST to support the provision of online
pharmaceutical services, besides the evident need to ac-
quire the technical skills that will allow and efficient and
safe provision of pharmaceutical care. The conditions
that have to be met in order to make online services ubi-
quitous in the country seem dependent of financial in-
centives and support from professional organizations, a
finding that confirms the results from the scenario
analysis.
The dispensing of medicines was found to be the most
significant pharmaceutical service provided. No struc-
tured medication management service or any other dis-
ease management service was observed, in spite of the
pharmacies claiming it was provided. This was an ex-
pected finding, and the main driver of the current
research project. After the development of pharmaceut-
ical care programs in the turn of the century, these
programs have started to wither away, with many phar-
macies dropping the provision of these programs [49].
The causes for this have long been discussed within the
profession and the reasons range from the lack of pay-
ment for these services to the professional inertia re-
garding the adoption of new forms of practice [50, 51].
Also, another barrier commonly cited has been the “lack
of time” reported by pharmacists [52, 53]. Analyzing our
results, there seems to exist a perception gap about
pharmacists’ free time. In reality, enough free time exists
to provide at least one consultation per day. More im-
portantly, the potential to find more time is there, if the
management of community pharmacies is reorganized,
with more clear roles for each of the professionals.
In the demonstration activity, pharmacists P also refer
“lack of time” as the reason to under-recruit and not
provide the necessary follow-up for the recruited users.
Pharmacists overestimated the time needed to recruit
patients referring that it would take at least 30 minutes
per patient. In reality, after measures done by the re-
searchers, the estimated time for recruitment was
18.32 minutes (about 60% of the pharmacists’ estima-
tion) tested in 12 interventions at real time at pharmacy
1, 2 and 3. Moreover, one other reason provided for the
low recruitment numbers was that pharmacists antici-
pated non-compliance with this type of intervention by
their usual chronic patients, confirming the experience
of other research projects in Portugal and elsewhere
[16, 54]. To overcome this issues, innovative recruit-
ment strategies must be considered and implemented
in future research projects.
The results with Pharmacist “C”, providing the service
in a community setting without a pharmacy infrastruc-
ture as support was a novelty. It has been advanced as a
possible form of practice for future pharmacists [55].
What this experiment showed is that being available to
capture patients’ interest and holding regular meetings
are important activities to keep the patient engaged with
his/her own disease management. The use of the per-
sonal profile and vital data graphics was an essential key
to empower patients on their health self-management,
enhancing their health condition perception allowing for
better user-acceptance, medication adherence and
healthy behaviors. Also of importance, the close
monitoring and sharing of information allowed the de-
tection of early signs of adverse reactions or potentially
dangerous interactions between medicines and non-
prescription products. By the end of the demonstration
activity, the patients were so engaged that they asked if
it was possible to continue to use the platform for data
registration because they were already familiar with its
functioning. These results show the high importance of
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continuing the research with new strategies to overcome
barriers at community pharmacies.
Implications for research
In this paper, the authors test DSRM as a method to de-
velop new online services, in an iterative process that
values end-users inputs. The use of design science to de-
velop technological artifacts to use in healthcare has
already demonstrated utility [56]. However, to our know-
ledge, the use of Peffers and colleagues [31] activities to
develop a new health service is a novelty. These guide-
lines have been subject to discussion by experts in the
field, [57] and hopefully this research work provides a
new example of DSRM application for health service re-
search. The DSRM activities were appropriate to study
the contributions of the proposed ePharmacare online
service to improve the interactions between pharmacists
and patients. Moreover, the results from this DSRM
cycle will inform the following research cycle.
Regarding the choice of methodology, the evaluation
of the artifact must fulfil the four Österle principles for
design-oriented information system research: abstrac-
tion, originality, justification and benefits [58]. The
ePharmacare platform completely fulfils these four
Österle principles by:
 Abstraction: ePharmacare may be used by
pharmacists or by any other health professional
ready to tackle chronic disease management and
medicine utilization at both public and private
health units. Data requirements are commonly
available in any pharmacy or healthcare center,
namely patient data, medicines interactions, etc.;
 Originality: ePharmacare was designed by a
multidisciplinary team including healthcare
professionals (e.g. pharmacists and GP) and patients,
contributing to the creation of a system oriented to
their real needs. For the first time the Dáder
methodology for patient follow-up and pharmaceutical
care was implemented in an online interactive system;
 Justification: According to the WHO, chronic diseases
are a major worldwide cause of death and healthcare
services burden [1]. ePharmacare is an online service
to help prevent, manage and control chronic
medication, validated by pharmacists and physicians;
 Benefits: the online service benefits healthcare
organizations and the society in general by providing
an integrated view of the patient and facilitating the
work of healthcare professionals, namely pharmacists
and general practitioners. It further contributes to
more informed chronic diseases management, once it
allows both pharmacists and physicians to check
patient data in their specific contexts, speeding up the
prescription decision process.
Service modelling
The modelling stage at the end of activity 2 yielded an
initial Service Experience Blueprint for the online ser-
vice. The prosecution of all DSRM’s activities allowed
the development of a new blueprint focusing on the
architecture of a community pharmacy based disease
management service. The SEB presented in Fig. 4 high-
lights the guidelines responsible for the service theater,
identifying several actors (on the left) and the flow of
possible actions throughout the service. This SEB also
defines where the service takes place and how is the cus-
tomer interacting with the service provider, as well as
possible waiting points and fail points.
Implications for pharmacy practice
Whether these professionals have the necessary skills to
provide online pharmaceutical care services is an aspect
that needs to be further explored. However, training pro-
vided on a web-platform with game-based learning,
practicing with cases from daily activities, is a future
possibility [59, 60]. Moreover, the social abilities that
these professionals do have may provide the basis to im-
prove the interaction experience with patients in a new
online service [51, 61]. This can be important consider-
ing that customer relationships is one of the key aspects
of the new services provided through the Internet.
One can argue that, for these developments to be
beneficial, they should be considered in an integrated
and longitudinal perspective of services provision, re-
quiring service’s events registering, comprehensive ana-
lysis of the data and interactive dialogue with patients
[62]. This perspective implies a new way of working in
community pharmacies. Some authors refer that it is ne-
cessary to create a new organization at community phar-
macies, not only to embrace pharmaceutical care, but
also to incorporate it into their business models [63].
Surely community pharmacies and their professionals
could play a more active role in chronic disease manage-
ment within the healthcare system. Embracing the
potential of the Internet to support the development
of an extended role for community pharmacists is
strategic [64].
With the integration of primary healthcare and
pharmaceutical services, data sharing portals such as the
online platform developed for this study will receive data
validated by primary healthcare professionals that are
also useful for pharmacists’ provision of disease manage-
ment services in the community. In a reciprocal way, the
data gathered by patients and caregivers in the same
portal, could be validated by community pharmacists be-
fore inclusion in the electronic health record used by
primary care professionals. Figure 5 depicts a possible
model for Health Information Systems integration. An
integrated health information system that provides the
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stakeholders of disease management with mechanisms
that assure accountability, credibility, acceptability
among other dimensions, would have the potential to
impact on several factors. On the professionals’ side, the
dimensions of trust, communication, “knowing each
other”, role definition and professional recognition and
certification will surely benefit of such a system. On
patients and caregivers’ side, an integrated system
may improve professionals’ needs assessment, while
providing tailored information through more frequent
communication on a low cost service, yielding a high
value disease management.
Innovation is a process implying the transformation of
ideas about a perceived problem into a new product,
process or service. Innovation in healthcare has usually a
direct impact on the quality of care services and on the
life of patients. The challenges posed by the rising preva-
lence of chronic diseases demand new strategies to
innovation in health [65]. The ultimate goal of technol-
ogy and innovation is to improve quality of life. Yet, all
Fig. 4 SEB for the new Disease Management service in community pharmacy (reproduced with author’s permission)[41]
Fig. 5 Conceptual model for the integration of Health Information Systems in Primary Healthcare
Lapão et al. BMC Medical Informatics and Decision Making  (2017) 17:31 Page 11 of 14
too often, introduction of new tools is decided by
policymakers and experts without genuinely involving
future users and those experiencing the potential risks
[21]. However, good business model designs are likely
to be context dependent, and both the design and im-
plementation processes are likely to involve iterative
processes [66].
The use of DSRM to implement an online pharma-
ceutical service offers a higher involvement to the stake-
holders. This involvement showed the potential to
develop a tailored information system. Furthermore, in
the problem definition stage of the DSRM cycle pre-
sented, several issues relating to community pharmacists
and pharmacies activities were identified. However, one
must limit these findings to participant pharmacies in
spite of the perception that these pharmacies provide a
picture of the large majority of the country’s pharmacies.
Caution is needed when interpreting the findings here
reported.
The Dáder methodology to provide patient follow-up
was chosen since it was the method used in the pioneer
pharmaceutical care programs implemented in Portugal.
All participant pharmacists who could provide pharma-
ceutical care were trained in this methodology. However,
one can argue that other methodologies for patient
follow-up namely, Medication therapy management
(MTM), were available and could offer a valid alterna-
tive. The low number of participants in the demonstra-
tion stage also hinders the results, namely the estimation
of the impact on health outcomes. In the next DSRM
cycle, a better recruiting strategy must be defined to in-
crease the number of participants, thus increasing the
likelihood of having the sufficient number of participants
to accurately assess the impact of online pharmaceutical
services on the health outcomes of chronic patients. As
it is an objective of a good DSRM study, a new cycle is
being prepared to further improve the online service,
this time focusing on improving the communication be-
tween pharmacists and physicians.
Conclusion
The recent evolution of IST (e.g. website and chronic
care sensors) is an important opportunity towards the
integration of new roles for community pharmacists
(within the healthcare system), while allowing a more ac-
tive role from patients in their disease management. The
ePharmacare platform presents a possible turning point
in the way business is done within community pharma-
cies, by reaching out to new channels and shifting the
focus from the sale of products to the provision of
services.
The use of DSRM helped implementing an online
pharmaceutical service through a higher involvement of
the stakeholders in a comprehensive way. Moreover, in
the problem definition stage of the DSRM cycle pre-
sented, several issues relating to community pharmacists
and pharmacies activities were identified. The patterns
of pharmacist time usage, the costing studies and the
patterns of service provision and demand, reflect a need
to reorganize pharmacies management and acquire add-
itional skills in order to enable online pharmaceutical
services provision.
The ePharmacare platform is able to offer pharmacies
a way to better monitor their patients and therefore in-
crease the quality of their therapy. By bringing to life a
needed tool, the platform fulfills the detected need for
IST in pharmaceutical services provision, offering pa-
tients a new way to interact with their data and be part
of their own therapy as active members on disease
management.
The quality and usability of the platform is critical. But
the platform is not everything. Developing and imple-
menting online services takes properly trained and moti-
vated professionals. Online pharmaceutical services need
to be more integrated in the current daily practices and
some communication and marketing efforts need to be
done, to recruit and demonstrate value to the chronic
patients. A rethinking of the community pharmacy busi-
ness model in order to effectively and coherently inte-
grate community pharmacies services into the future
health system models, where patients will have an in-
creasing role in disease management, is paramount.
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